Eva Bräunlein

NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data

Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors

A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

Regulation and Functions of the ER-Associated Nrf1 Transcription Factor

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Post-Translational Peptide Splicing and T Cell Responses

CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment

Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different

Novel tools to assist neoepitope targeting in personalized cancer immunotherapy

Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer

Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data

The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences

Peptide-binding specificity prediction using fine-tuned protein structure prediction networks

Universal Spectrum Explorer: A Standalone (Web-)Application for Cross-Resource Spectrum Comparison

Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry

Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients